{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:36:12Z","timestamp":1758396972211},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>The high-sensitivity cardiac troponin I (hs-cTnI) in serum can increase due to an increase in left ventricular (LV) overload in individuals with hypertension. Since LV voltage on an electrocardiogram (ECG) reflects LV load, it is possible that LV voltage is closely associated with hs-cTnI in individuals without hypertension. This study investigated the association between LV voltage indices and serum hs-cTnI levels in normotensive Japanese individuals.<\/jats:p>\n            <jats:p>Subjects who visited the Enshu Hospital for a health check-up were screened for their eligibility. Subjects with renal dysfunction, cancer, active inflammatory disease, or a history of cardiovascular events were excluded, as were subjects with obvious ST segment or T wave abnormality, Wolff\u2013Parkinson\u2013White syndrome, pacemaker implantation, or frequent arrhythmia in the ECG. Exclusion of individuals with hypertension left 803 subjects (54.8\u200a\u00b1\u200a11.3 years) for final inclusion. The R wave voltage in lead V5 (RV5 voltage), the Sokolow\u2013Lyon voltage (a sum of the QRS wave (a complex wave consists of Q, R, and S wave) of the S wave voltage in lead V1 and the R wave voltage in lead V5), and the Cornell product (a product of QRS duration and QRS voltage) were evaluated by ECG as LV voltage indices. Laboratory measurements included serum hs-cTnI levels. Possible associations between indices of LV voltage on ECG and serum hs-cTnI levels were cross-sectionally investigated in the normotensive subjects.<\/jats:p>\n            <jats:p>The median values [interquartile range] of hs-cTnI and BNP were and 2.1 [1.4\u20133.0] and 13.8 [7.7\u201324.9] pg\/mL, respectively. Multivariate regression analysis identified that the levels of hs-cTnI, but not BNP, were significantly associated with RV5 voltage (<jats:italic toggle=\"yes\">\u03b2<\/jats:italic> 0.090, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.0087), Sokolow\u2013Lyon voltage (<jats:italic toggle=\"yes\">\u03b2<\/jats:italic> 0.112, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.0009), and Cornell product (<jats:italic toggle=\"yes\">\u03b2<\/jats:italic> 0.101, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.039) after adjustment for possible confounding factors. Moreover, the RV5 voltage, Sokolow\u2013Lyon voltage, and Cornell product were significantly associated with the hs-cTnI levels after adjustment for possible confounding factors including ECG findings (<jats:italic toggle=\"yes\">\u03b2<\/jats:italic> 0.109, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.0075; <jats:italic toggle=\"yes\">\u03b2<\/jats:italic> 0.125, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.0010; and <jats:italic toggle=\"yes\">\u03b2<\/jats:italic> 0.096, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.0116, respectively).<\/jats:p>\n            <jats:p>Indices of LV voltage in ECG had close associations with serum hs-cTnI levels in normotensive subjects. These findings support that the ECG findings of LV voltage have significant associations with slight myocardial micro-damage even in normotensive subjects.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000019992","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T20:37:33Z","timestamp":1588970253000},"page":"e19992","source":"Crossref","is-referenced-by-count":2,"title":["Indices of left ventricular voltage on electrocardiogram are closely associated with serum cardiac troponin I levels in normotensive Japanese individuals"],"prefix":"10.1097","volume":"99","author":[{"given":"Tatsuya","family":"Mizoguchi","sequence":"first","affiliation":[{"name":"Department of Cardiology, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Sugiura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuaki","family":"Dohi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Rehabilitation Sciences, Nagoya Gakuin University, Nagoya"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Takase","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Enshu Hospital, Hamamatsu"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Asahikawa Medical University, Asahikawa, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Seo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Ohte","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya City University Graduate School of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,5]]},"reference":[{"key":"R1-20240308","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0735-1097(01)01388-2","article-title":"The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis","volume":"38","author":"Heidenreich","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R2-20240308","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJMoa0900428","article-title":"Early diagnosis of myocardial infarction with sensitive cardiac troponin assays","volume":"361","author":"Reichlin","year":"2009","journal-title":"N Engl J Med"},{"key":"R3-20240308","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/eurheartj\/ehr376","article-title":"Early diagnosis of acute myocardial infarction in patients with pre-existing coronary artery disease using more sensitive cardiac troponin assays","volume":"33","author":"Reiter","year":"2012","journal-title":"Eur Heart J"},{"key":"R4-20240308","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1161\/CIRCULATIONAHA.116.025505","article-title":"High-sensitive cardiac troponin T as an early biochemical signature for clinical and subclinical heart failure: MESA (multi-ethnic study of atherosclerosis)","volume":"135","author":"Seliger","year":"2017","journal-title":"Circulation"},{"key":"R5-20240308","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/01.CIR.0000084543.79097.34","article-title":"Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure","volume":"108","author":"Horwich","year":"2003","journal-title":"Circulation"},{"key":"R6-20240308","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1001\/jama.2010.1708","article-title":"Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults","volume":"304","author":"deFilippi","year":"2010","journal-title":"JAMA"},{"key":"R7-20240308","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s00392-016-1026-5","article-title":"Factors independently associated with cardiac troponin I levels in young and healthy adults from the general population","volume":"106","author":"Bossard","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"R8-20240308","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/ajh\/hpu226","article-title":"Relationship between high-sensitivity cardiac troponin I and blood pressure among young and healthy adults","volume":"28","author":"Aeschbacher","year":"2015","journal-title":"Am J Hypertens"},{"key":"R9-20240308","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3109\/10641969309037090","article-title":"Left ventricular hypertrophy and hypertension","volume":"15","author":"Devereux","year":"1993","journal-title":"Clin Exp Hypertens"},{"key":"R10-20240308","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/01.CIR.102.4.470","article-title":"Left ventricular hypertrophy: pathogenesis, detection, and prognosis","volume":"102","author":"Lorell","year":"2000","journal-title":"Circulation"},{"key":"R11-20240308","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/ajh.2008.16","article-title":"Left ventricular hypertrophy and clinical outcomes in hypertensive patients","volume":"21","author":"Ruilope","year":"2008","journal-title":"Am J Hypertens"},{"key":"R12-20240308","doi-asserted-by":"crossref","first-page":"e3483","DOI":"10.1097\/MD.0000000000003483","article-title":"Use of electrocardiography to predict future development of hypertension in the general population","volume":"95","author":"Takase","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R13-20240308","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jash.2018.05.003","article-title":"Findings relevant to the QRS wave in the resting electrocardiogram are associated with circulating concentrasions of high-sensitivity cardiac troponin I in the general population","volume":"12","author":"Sugiura","year":"2018","journal-title":"J Am Soc Hypertens"},{"key":"R14-20240308","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","article-title":"The Japanese society of hypertension guidelines for the management of hypertension (JSH 2019)","volume":"42","author":"Umemura","year":"2019","journal-title":"Hypertens Res"},{"key":"R15-20240308","doi-asserted-by":"crossref","first-page":"846","DOI":"10.5551\/jat.GL2017","article-title":"Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017","volume":"25","author":"Kinoshita","year":"2018","journal-title":"J Atheroscler Thromb"},{"key":"R16-20240308","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.2040-1124.2010.00074.x","article-title":"Report of the committee on the classification and diagnostic criteria of diabetes mellitus","volume":"1","author":"Seino","year":"2010","journal-title":"J Diabetes Investig"},{"key":"R17-20240308","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1001\/jama.292.19.2343","article-title":"Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events","volume":"292","author":"Okin","year":"2004","journal-title":"JAMA"},{"key":"R18-20240308","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/hrt.2005.083949","article-title":"Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme","volume":"93","author":"Hawkins","year":"2007","journal-title":"Heart"},{"key":"R19-20240308","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0002-8703(49)90562-1","article-title":"The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads","volume":"37","author":"Sokolow","year":"1949","journal-title":"Am Heart J"},{"key":"R20-20240308","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/0735-1097(92)90376-X","article-title":"Electrocardiographic detection of left ventricular hypertrophy by the simple QRS voltage duration product","volume":"20","author":"Molloy","year":"1992","journal-title":"J Am Coll Cardiol"},{"key":"R21-20240308","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0735-1097(94)00371-V","article-title":"Electrocardiographic identification of increased left ventricular mass by simple voltage duration products","volume":"25","author":"Okin","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"R22-20240308","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan intervention for endpoint reduction in hypertension study (LIFE); a randomised trial against atenolol","volume":"359","author":"Dahl\u00f6f","year":"2002","journal-title":"Lancet"},{"key":"R23-20240308","doi-asserted-by":"crossref","first-page":"e106947","DOI":"10.1371\/journal.pone.0106947","article-title":"Evaluation of differences in automated QT\/QTc measurements between Fukuda Denshi and Nihon Koden systems","volume":"9","author":"Sano","year":"2014","journal-title":"PLoS One"},{"key":"R25-20240308","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jacc.2008.12.015","article-title":"AHA\/ACCF\/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology","volume":"53","author":"Hancock","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R26-20240308","doi-asserted-by":"crossref","first-page":"606","DOI":"10.4070\/kcj.2012.42.9.606","article-title":"A comparison of Cornell and Sokolow-Lyon electrocardiographic criteria for left ventricular hypertrophy in Korean patients","volume":"42","author":"Park","year":"2012","journal-title":"Korean Circ J"},{"key":"R27-20240308","doi-asserted-by":"crossref","first-page":"244","DOI":"10.21037\/cdt.2017.01.16","article-title":"A comparison of Cornell and Sokolow-Lyon electrocardiographic criteria for left ventricular hypertrophy in a military male population in Taiwan: the cardiorespiratory fitness and hospitalization events in armed forces study","volume":"7","author":"Su","year":"2017","journal-title":"Cardiovasc Diagn Ther"},{"key":"R28-20240308","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension","volume":"36","author":"Williams","year":"2018","journal-title":"J Hypertens"},{"key":"R29-20240308","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.cardfail.2005.04.025","article-title":"Circulating levels of myocardial proteins predict future deterioration of congestive heart failure","volume":"11","author":"Sugiura","year":"2005","journal-title":"J Card Fail"},{"key":"R30-20240308","doi-asserted-by":"crossref","first-page":"e5703","DOI":"10.1097\/MD.0000000000005703","article-title":"Prognostic value of basal high-sensitive cardiac troponin levels on mortality in the general population: a meta-analysis","volume":"95","author":"van der Linden","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"R31-20240308","doi-asserted-by":"crossref","first-page":"6610","DOI":"10.1038\/s41598-017-06978-3","article-title":"Troponin I and T in relation to cardiac injury detected with electrocardiography in a population-based cohort - the Maastricht Study","volume":"7","author":"Kimenai","year":"2017","journal-title":"Sci Rep"},{"key":"R32-20240308","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1161\/CIRCULATIONAHA.118.038772","article-title":"High-sensitivity troponin I and incident coronary events, stroke, heart failure hospitalization, and mortality in the ARIC study","volume":"139","author":"Jia","year":"2019","journal-title":"Circulation"},{"key":"R33-20240308","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/ajh\/hpx067","article-title":"Electrocardiographic left ventricular hypertrophy predicts cardiovascular morbidity and mortality in hypertensive patients: the ALLHAT study","volume":"30","author":"Bang","year":"2017","journal-title":"Am J Hypertens"},{"key":"R34-20240308","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/hr.2016.176","article-title":"Left ventricular hypertrophy by electrocardiogram as a predictor of success in home blood pressure control: HOMED-BP study","volume":"40","author":"Tanabe","year":"2017","journal-title":"Hypertens Res"},{"key":"R35-20240308","first-page":"1","article-title":"Masked hypertension is associated with end organ damage in geriatric age: geriatric MASked hypertension and end organ damage (G-MASH-end organ study)","volume":"12","author":"Esme","year":"2019","journal-title":"Blood Press"},{"key":"R36-20240308","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0008-6363(01)00320-0","article-title":"Measurement of plasma brain natriuretic peptide level as a guide for cardiac overload","volume":"51","author":"Hirata","year":"2001","journal-title":"Cardiovasc Res"},{"key":"R37-20240308","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jchf.2013.11.007","article-title":"Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis","volume":"2","author":"Savarese","year":"2014","journal-title":"JACC Heart Fail"},{"key":"R38-20240308","doi-asserted-by":"crossref","first-page":"e58287","DOI":"10.1371\/journal.pone.0058287","article-title":"Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials","volume":"8","author":"Savarese","year":"2013","journal-title":"PLoS One"},{"key":"R39-20240308","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2362.2004.01301.x","article-title":"Brain natriuretic peptide in the prediction of recurrence of angina pectoris","volume":"34","author":"Takase","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"R40-20240308","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1291\/hypres.31.1737","article-title":"Does B-type natriuretic peptide predict the new onset of hypertension?","volume":"31","author":"Takase","year":"2008","journal-title":"Hypertens Res"},{"key":"R41-20240308","first-page":"674","article-title":"Prediction of atrial fibrillation by B-type natriuretic peptide","volume":"5","author":"Takase","year":"2013","journal-title":"J Atr Fibrillation"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019992","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T20:13:22Z","timestamp":1709928802000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":40,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000019992","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}